Following three months of intense back pain, Gail McCray was diagnosed with multiple myeloma in 2008. After ASCT, she went through 7 years of remission before having a relapse but found a regimen that put her into sCR for a second time. Gail is a Community Health Educator working to close the gap between health care providers and community/individual health and to get patients to be more involved with their health. She is focused on translating research into practice and on the end-user of bioresearch. Gail has been a co-leader of the Southside Atlanta MM Support Group for 12 years. This is Gail’s second time attending the ASH conference. New therapies, upcoming clinical trials, genetics, genomics, precision medicine, and research determining disparities in the incidence of myeloma in African Americans and other ethnic groups are Gail’s topics of interest.

Follow Gail on Twitter: @IMFgailMYELOMA
Support Group Website: Southside Atlanta MM Support Group

 

Post-ASH Reflections

Post-ASH Reflections

The ASH21 Meeting of blood diseases is in the books. What I can share with patients, care partners, and all who are interested is that the myeloma research world is on fire! There are so many new questions for new and veteran researchers, so many creative possible solutions were a part of this annual meeting with a usual attendance of 30,000 health professionals with interests in hematology.  I wanted to share the many advancements being made in the myeloma world – to be able to...

read more
The Words Are HOPE and GRATITUDE

The Words Are HOPE and GRATITUDE

As I reflect on the end of this first official day of the ASH Conference, I must say that I feel HOPE and GRATITUDE. I pored over the very complicated ASH Agenda. The IMF-SGL team of veterans and newbies is well-organized and so generous with sharing lessons, hints, and strategies to get the most out of this opportunity. My focus was on studying the agenda and setting my personal ASH schedule, listening to pre-recorded sessions, and participating in the day's live educational sessions. I came...

read more
Pre-ASH Blog: New Myeloma Science at ASH: Health Equity at the Curbside

Pre-ASH Blog: New Myeloma Science at ASH: Health Equity at the Curbside

Well, everyone.  We are in the week leading up to a major annual international conference, the American Society Hematology (ASH). During this meeting, bench and clinical myeloma research from all over the world will be presented and discussed.   I am excited, humbled, and fearful at the same time. I am humbled at this tremendous opportunity afforded to me by the IMF. I would love to see and hear everything over the 4 official...

read more